Breast density, a key factor in breast cancer risk, is now disclosed to U.S. patients after every mammogram.
Breast density and cancer risk
Breast density refers to the proportion of fibroglandular tissue compared to fatty tissue in the breast. This characteristic can influence a person’s risk of developing breast cancer, making it an important factor in health assessments.
New U.S. regulations on mammograms
In the United States, new rules now require that every mammogram report include information about a patient’s breast density. This change was mandated by the Food and Drug Administration and aims to improve awareness and understanding of this factor among patients.
Dense breast tissue is common
Approximately half of women over 40 in the United States have dense breast tissue. This prevalence underscores the importance of the new regulation, as it affects a significant portion of the population and may impact cancer risk.
No automatic tests for dense breasts
The new guidelines do not automatically recommend additional tests for women with dense breasts. Instead, they encourage these individuals to discuss their results and potential next steps with their healthcare providers.
